Estrella Immunopharma share price logo

Estrella Immunopharma

NASDAQ: ESLA

$0.84

-0.10

(-10.19%)

as on

Estrella Immunopharma Stock Performance

as on October 29, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.75
    $0.99
    downward going graph

    10.43%

    Downside

    18.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.24
    $3.15
    downward going graph

    71.34%

    Downside

    276.21%

    Upside

    downward going graph

Estrella Immunopharma share price movements today

Previous Close
$0.93
Open
$0.90
Volume
1.1M
Market Cap
$40.0M
Day's Low - High
$0.75 - $0.99
52 Week Low - High
$0.24 - $3.15

Estrella Immunopharma Historical Returns

1 Month Return
+ 116.11 %
3 Month Return
+ 24.56 %
1 Year Return
-62.26 %
3 Year Return
-43.84 %
5 Year Return
0 %

Estrella Immunopharma Stock Fundamentals & Key Indicators

Check Estrella Immunopharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$40.0M

EPS (TTM)

-0.2462

Dividend Yield

0.00%

PE Ratio (TTM)

-3.73

Industry PE ratio

-2.70

PEG Ratio

-0.20

Return On Equity TTM

121.72%

Estrella Immunopharma vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Estrella Immunopharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$40.0MNA-3.730.00%0.00%
Neutral$79.4B-40.22%-24.92-12.57%0.00%
StrongBuy$131.2B186.28%29.8886.04%0.00%
Buy$83.2B30.54%19.2984.86%0.46%

Stock Returns calculator for Estrella Immunopharma Stock including INR - Dollar returns

The Estrella Immunopharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Estrella Immunopharma investment value today

Current value as on today

₹36,583

Returns

-₹63,417

(-63.42%)

Returns from Estrella Immunopharma Stock

-₹66,101 (-66.1%)

Dollar Impact

₹2,684 (+2.68%)

Indian Investors' Interest in Estrella Immunopharma Stock

Search interest for Estrella Immunopharma Stock has increased by 2475% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2475% versus previous 30 day period

Estrella Immunopharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
0
-3
-3
-1
-2
-5
-4
0
-2
-2
EBITDA
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Income Tax Expense
-
0
-
0
0
0
-
0
-
-
Net Income
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Estrella Immunopharma Annual Profit & Loss

All numbers in Millions USD

Jun 2021
Dec 2021
Dec 2022
Jun 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
0
-1
-11
-7
-8
-13
EBITDA
0
-1
-11
-7
-8
-13
Interest Expense
-
-
-
-
-
-
Depreciation
0
-
-
-
-
-
Income Before Tax
0
-1
-11
-7
-8
-13
Income Tax Expense
-
-
-
0
0
0
Net Income
0
-1
-11
-7
-8
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Estrella Immunopharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-3
-3
-1
-2
-5
-4
0
-2
-2
Operating Cash Flow
-15
0
-2
0
0
0
0
0
-6
-1
Investing Cash Flow
4
-
-
-
-
-
-
-
-
-
Financing Cash Flow
13
0
0
0
0
1
1
0
7
0
Change in Cash
4
0
-2
0
0
0
0
0
0
-1

Estrella Immunopharma Annual Cash Flow

All numbers in Millions USD

Jun 2021
Dec 2021
Dec 2022
Jun 2024
Dec 2024
Dec 2025
Net Income
0
-1
0
-7
-8
-13
Operating Cash Flow
0
-1
-1
-16
-3
-1
Investing Cash Flow
-
-
36
4
-
-
Financing Cash Flow
0
5
-35
12
0
2
Change in Cash
-
4
0
1
0
0

Global Institutional Holdings in Estrella Immunopharma

Check out the Institutions with significant holdings in Estrella Immunopharma.

Funds
Holdings
Vanguard
0.96%
VANGUARD INDEX FUNDS
0.88%
Fidelity Concord Street Trust
0.22%
iShares
0.10%

Insights on Estrella Immunopharma

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ESLA stock has moved up by 69.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 720.4% return, outperforming this stock by 782.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 189.2% return, outperforming this stock by 233.0%

About Estrella Immunopharma

Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States. The company's lead investigational drugs include EB103, which is in preclinical development for diffuse large B-cell lymphoma, and EB104, intended for the treatment of both diffuse large B-cell lymphoma and acute lymphocytic leukemia. Estrella also maintains a collaborative agreement with Imugene Limited, working together to develop solid tumor therapies that integrate Imugene's CF33-CD19t product candidate with Estrella's EB103. The company is based in Emeryville, California.
OrganisationEstrella Immunopharma
Headquarters5858 Horton Street, EmeryVille, CA, 94608, US
IndustryBiotechnology
CEOCheng Liu

Key Management of Estrella Immunopharma

Name

Title

Dr. Cheng Liu Ph.D.

CEO, President & Director

Mr. Jiandong Xu

Chief Financial Officer

FAQs

What is Estrella Immunopharma share price today?

Estrella Immunopharma share price today is $0.84 as on at the close of the market. Estrella Immunopharma share today touched a day high of $0.99 and a low of $0.75.

What is the 52 week high and 52 week low for Estrella Immunopharma share?

Estrella Immunopharma share touched a 52 week high of $3.15 on and a 52 week low of $0.24 on . Estrella Immunopharma stock price today i.e. is closed at $0.84,which is 73.42% down from its 52 week high and 248.88% up from its 52 week low.

What is Estrella Immunopharma's market capitalisation today?

Estrella Immunopharma market capitalisation is $0.00T as on .

How to invest in Estrella Immunopharma Stock (ESLA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Estrella Immunopharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Estrella Immunopharma Stock (ESLA) from India?

Indian investors can start investing in Estrella Immunopharma (ESLA) shares with as little as ₹95.22000122070312 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.20 in Estrella Immunopharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Estrella Immunopharma share’s latest price of $0.84 as on October 29, 2026 at 1:29 am IST, you will get 11.9432 shares of Estrella Immunopharma. Learn more about fractional shares .